BRWD3
protein-codingbromodomain and WD repeat domain containing 3, the group of WD repeat domain containing|Bromodomain containing
Gene summary
The protein encoded by this gene contains a bromodomain and several WD repeats. It is thought to have a chromatin-modifying function, and may thus play a role in transcription. Mutations in this gene are associated with a spectrum of cognitive disabilities and X-linked macrocephaly. This gene is also associated with translocations in patients with B-cell chronic lymphocytic leukemia. [provided by RefSeq, Jul 2017]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~140.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0007295
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0010393
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0018097
Submitter: Ambry Genetics
Inheritance Pattern: XL
Disease ID:MONDO:0020119
Submitter: ClinGen
*BRWD3* is located on chromosome Xq21.1 and encodes a bromodomain‐ and WD40 repeat–containing protein involved in the regulation of chromatin dynamics, cytoskeletal organization, and intracellular signaling. *BRWD3* was first reported in relation to X-linked syndromic intellectual disability in 2007 (Field et al., PMID: 17668385). Affected males exhibit developmental delay, intellectual disability, speech delay, macrocephaly, overgrowth, and variable dysmorphic features. Some individuals also exhibit obesity or overweight, behavioral disturbances (including autism and ADHD) or epilepsy. Female carriers are typically unaffected but some exhibit mild cognitive impairment. Ten variants (5 nonsense, 3 frameshift, 1 splice, and 1 missense) that have been reported in ten probands in three publications (PMIDs: 17668385, 24462886, 28475857) are included in this curation. The missense variant has no functional evidence of pathogenicity and was given a score of 0. When segregation information was available, the variants were inherited from unaffected mothers. In several cases, the variants were shown to segregate with disease in additional family members. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. The mechanism of pathogenicity is loss of function. Emerging experimental evidence (primarily studies in Drosophila) also supports this gene-disease relationship. In summary, there is definitive evidence supporting the relationship between *BRWD3* and X-linked syndromic intellectual disability. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on July 18, 2018 (SOP Version 5). As of August 2026, this record underwent administrative updates to update scoring to be consistent with SOP Version 12. No new evidence was added.
Inheritance Pattern: XL
Disease ID:MONDO:0010393
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: XL
Disease ID:MONDO:0010393
Submitter: G2P
Inheritance Pattern: XL
Disease ID:MONDO:0010393
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Genitourinary; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to BRWD3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_153252.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 59 | 133 | 12 | 204 | ||
| missense | 3 | 6 | 532 | 44 | 6 | 591 |
| nonsense | 18 | 16 | 22 | 56 | ||
| start loss | 1 | 1 | ||||
| frameshift | 14 | 12 | 3 | 29 | ||
| splice donor/acceptor (+/-2bp) | 3 | 9 | 55 | 67 | ||
| Total | 38 | 44 | 671 | 177 | 18 | 948 |
Highest pathogenic variant AF is 0.0000036462982
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_694984.5 | 41 | MANE Select | |
| Ensembl | ENSP00000362372.4 | 41 | MANE Select | |
| RefSeq | NP_001428268.1 | 40 | Standard | |
| Ensembl | ENSP00000779911.1 | 21 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- regulation of transcription by RNA polymerase II
- cytoskeleton organization
- regulation of cell shape
Cellular Component
- nucleus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000373275
- Coding exons
- 41
- Length
- 138835
- Individuals with no LoFs
- 125725
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 4
- Defined
- 125729
- p
- 0.0000159
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 4.27 | 369 | 683 | 0.540 | 0.0000516 | 11844 |
| Missense (PolyPhen) | 70 | 193.72 | 0.36134 | 3392 | ||
| Synonymous | -0.904 | 242 | 225 | 1.08 | 0.0000161 | 3374 |
| Loss of Function | 7.83 | 2 | 75.4 | 0.0265 | 0.00000587 | 1253 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000037 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000088 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000028 | 0.000018 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the control of cell shape. {ECO:0000269|PubMed:21834987}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving BRWD3 can be found in patients with B-cell chronic lymphocytic leukemia (B- CLL). Translocation t(X;11)(q21;q23) with ARHGAP20 does not result in fusion transcripts but disrupts both genes.; DISEASE: Mental retardation, X-linked 93 (MRX93) [MIM:300659]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Intellectual deficiency is the only primary symptom of non- syndromic X-linked mental retardation, while syndromic mental retardation presents with associated physical, neurological and/or psychiatric manifestations. MRX93 is associated with macrocephaly. {ECO:0000269|PubMed:17668385}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0991
Intolerance Scores
- LoFtool
- 0.0934
- RVIS EVS
- -0.49
- RVIS percentile EVS
- 22.65
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.694
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |